NewsPronto

 
Men's Weekly

.

ACN Newswire

Read more press releases from ACN Newswire here

Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP Study of NVK-002

  • Written by ACN Newswire

image

HONG KONG, Nov 12, 2020 - (ACN Newswire) - Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd. ("Zhaoke Hong Kong") is pleased to announce today that the first patient has completed three year enrollment in the Phase III CHAMP (Childhood Atropine for Myopia Progression) study carried out by its partner, Nevakar Inc. ("Nevakar"). The CHAMP Study...

Read more: Zhaoke Ophthalmology Announced First Patient Completes Three Year Enrollment in Phase III CHAMP...